Repligen | RGEN - 負債





負債 変化する 日付
Agilent USD 3.35B 55M 2025-09
Align Technology USD 114.45M 6.82M 2025-12
Bio Techne USD 200M 60M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Bruker USD 2.04B 34.4M 2025-12
Charles River Laboratories USD 2.57B 58.23M 2025-12
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
General Electric Aerospace USD 20.28B 217M 2026-03
Henry Schein USD 3.75B 313M 2026-03
Illumina USD 2.55B 23M 2025-12
IQVIA Holdings USD 15.83B 109M 2026-03
Mettler Toledo International USD 2.15B 57.69M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pfizer USD 63.73B 231M 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Standard Biotools USD 27.39M 1.23M 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Waters USD 1.49B 4.92M 2025-12
West Pharmaceutical Services USD 202.8M 0 2026-03